Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      Homepharma stocks

      pharma stocks

      Price Target Update on Spectrum Pharmaceuticals, Inc.
      Health

      Price Target Update on Spectrum Pharmaceuticals, Inc.

      October 24, 2017
      3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug
      Drugs

      3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug

      October 24, 2017
      Head-to-Head: Impax Laboratories VS. SCYNEXIS
      Health

      Head-to-Head: Impax Laboratories VS. SCYNEXIS

      October 24, 2017
      Is Impax Laboratories a Buy At $16?
      Health Services

      Is Impax Laboratories a Buy At $16?

      October 20, 2017
      Impax Laboratories Inc: A Technical Snapshot
      Healthcare

      Impax Laboratories Inc: A Technical Snapshot

      October 19, 2017
      An Analysis of pSivida Corp.
      Drugs

      An Analysis of pSivida Corp.

      October 2, 2017
      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating
      Healthcare

      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

      September 26, 2017
      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC
      Healthcare

      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

      September 21, 2017
      ImmunoGen had an Impressive 12% Climb Today
      Health

      ImmunoGen had an Impressive 12% Climb Today

      August 30, 2017
      Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval
      Health

      Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval

      August 25, 2017
      « 1 2 3 4 5 6 »

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026